New stroke drug LT3001 passes early safety check in healthy adults
NCT ID NCT04809818
First seen Dec 26, 2025 · Last updated May 24, 2026 · Updated 21 times
Summary
This early-stage study tested the safety of a new drug called LT3001, which is being developed for acute ischemic stroke. Researchers gave the drug to 65 healthy adults to see how it interacts with common medications like aspirin and blood thinners. The goal was to check for side effects and how the drug moves through the body, not to treat stroke. This is a first step before testing in stroke patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Lumosa Phase 1 Unit
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.